Risk of malignant lymphoma in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs and methotrexate .
CONCLUSION: The present study shows that using infliximab further increases the risk of malignant lymphoma in patients receiving methotrexate therapy.
.
PMID: 30526810 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research
More News: Arthritis | Canada Health | Cancer & Oncology | Databases & Libraries | Drugs & Pharmacology | Hodgkin's Disease | Japan Health | Lymphoma | Methotrexate | Non-Hodgkin's Lymphoma | Remicade | Rheumatoid Arthritis | Rheumatology | Study